 | Up a level |
Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha 
ORCID: 0000-0003-4927-7484, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva ORCID: 0000-0001-7752-4126, Acker, Fabian ORCID: 0000-0002-6207-0237, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caille, Leandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars ORCID: 0000-0002-5890-5510, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter and Dietrich, Sascha
(2021).
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Blood Adv., 5 (13).
S. 2707 - 2717.
AMSTERDAM:
ELSEVIER.
ISSN 2473-9537
Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Bruemmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Haenel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Moehle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Koehne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Mueller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Truemper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Joerg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wuendisch, Thomas, Geer, Thomas, Bildat, Stephan, Schaefer, Erhardt, Hasford, Joerg, Hehlmann, Ruediger and Pfirrmann, Markus (2019). Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica, 104 (5). S. 955 - 963. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078